Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Plos One|February 20, 2014
Systemic delivery of siRNA down regulates brain prion protein and ameliorates neuropathology in prion disorderSylvain Lehmann, Aroa Relano-Gines, Sarah Resina, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 18, 2025
Perioperative Management With Efanesoctocog Alfa in Patients With Haemophilia A in the Phase 3 XTEND-1 and XTEND-Kids StudiesRobert Klamroth, Annette von Drygalski, Cedric Hermans, et al.
Revista Espanola De Enfermedades Digestivas|February 6, 2020
Endoscopic submucosal dissection for gastric epithelial lesions: long-term results in a Spanish cohortÁngel Cañete Ruiz, Julia Arribas Anta, Teresa Alvarez-Nava Torrego, et al.
Expert Review of Hematology|December 23, 2022
Development of a telematic pharmaceutical care app (Haemoassist) for multidisciplinary follow-up of patients with congenital coagulopathiesNuria Blazquez-Ramos, José A Romero-Garrido, Luis Gonzalez Del Valle, et al.
Plos Neglected Tropical Diseases|April 24, 2020
Study of Usutu virus neuropathogenicity in mice and human cellular modelsMarion Clé, Jonathan Barthelemy, Caroline Desmetz, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 2, 2022
Clinical Efficacy and Safety of Fanhdi<sup>®</sup>, a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective StudyVíctor Jiménez-Yuste, María Teresa Alvarez-Román, Ángeles Palomo Bravo, et al.
International Journal of Hematology|July 2, 2017
Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practiceTomás José González-López, Fernando Fernández-Fuertes, José Angel Hernández-Rivas, et al.
British Journal of Haematology|December 19, 2014
Use of eltrombopag after romiplostim in primary immune thrombocytopeniaJosé Ramón González-Porras, María Eva Mingot-Castellano, Marcio M Andrade, et al.
European Journal of Haematology|December 29, 2015
Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practiceTomás José González-López, María Teresa Alvarez-Román, Cristina Pascual, et al.
Blood|August 24, 2012
Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopeniaTadeusz Robak, Jerzy Windyga, Jacek Trelinski, et al.
Pageof 12